[Ad hoc announcement pursuant to Art. 53 LR] Roche records solid results for the first nine months of 2022
Basel, 18 October 2022Group salesup 2%1 at constant exchange rates (CER) and 1% in Swiss francs; as expected, significantly lower COVID-19-related sales in both divisions in the third quarterSales in the Pharmaceuticals Divisionat the previous year ’s level with significantly lower sales of COVID-19-related products (Ronapreve and Actemra/RoActemra) and losses to biosimilars, offset by strong growth of newer medicinesSales in the Diagnostics Divisionrise 6%; base business remains strong; as expected, demand for COVID-19 tests sharply down in third quarterHighlights in the third quarter:EU approval forVabysmo (severe eye ...
Source: Roche Media News - October 18, 2022 Category: Pharmaceuticals Source Type: news
FAPI-PET predicts outcomes in patients with esophageal cancer
PET imaging with a fibroblast activation protein inhibitor (FAPI) radiotrace...Read more on AuntMinnie.comRelated Reading:
FAPI-PET shows promise detecting biliary tract cancer
Dual-tracer PET/CT shows promise in cancer imaging
FAPI-PET may improve diagnosis of gastric cancer
PET imaging lays foundation for new cancer therapies
New PET radiotracer more effective at detecting cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 17, 2022 Category: Radiology Source Type: news
STELARA ® (ustekinumab) Demonstrated Sustained Symptomatic and Corticosteroid-Free Remission Through Four Years in Adults with Moderately to Severely Active Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced final data from the long-term extension (LTE) of the Phase 3 UNIFI study demonstrating efficacy and safety of STELARA® (ustekinumab) through four years of treatment in adult patients with moderately to severely active ulcerative colitis (UC).1 Among all patients who had achieved clinical responsea with STELARA during induction, 64.9 percent were in symptomatic remissionb after 44 weeks of maintenance. At week 200 (four years), this proportion of patients was 55.2 percent; the majority (96.4 percen...
Source: Johnson and Johnson - October 10, 2022 Category: Pharmaceuticals Source Type: news
Results of Novel Clinical Study of Guselkumab and Golimumab Combination Therapy Show Adults with Moderately to Severely Active Ulcerative Colitis Maintained Higher Rates of Clinical, Histologic, and Endoscopic Remission at Week 38
SPRING HOUSE, PENNSYLVANIA, October 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from an ongoing analysis of a Phase 2a clinical trial showing adults with moderately to severely active ulcerative colitis (UC) who received 12 weeks of combination induction therapy with guselkumab and golimumab, followed by a transition to guselkumab alone for maintenance, achieved a clinical remission ratea (based on the modified Mayo score [mMayo])b at week 38 of 47.9 percent, a higher rate than induction and maintenance treatment with either guselkumab alone (31.0 percent) or golimumab al...
Source: Johnson and Johnson - October 10, 2022 Category: Pharmaceuticals Source Type: news
The Race to Make a Vaccine for Breast Cancer
When Karen Lynch was diagnosed with breast cancer at age 44, it was a shock, but not a complete surprise. “My family history is just riddled with cancer; my father had prostate cancer and died from stomach and esophageal cancer, and his five sisters passed from breast cancer,” she says. “My mother died from pancreatic cancer.” It was 1996, and genetic testing was not as routine as it is now, so it wasn’t until nine years after her diagnosis and treatment with lumpectomy and radiation that Lynch learned she carried the BRCA1 mutation, which increases her risk of breast cancer and ovarian cancer...
Source: TIME: Health - October 6, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer feature Frontiers of Medicine 2022 healthscienceclimate sponsorshipblock Source Type: news
Cancer: The feeling after ‘drinking or eating’ suggestive of stomach cancer - initial sign
Recognising symptoms in the initial stages of stomach cancer significantly increases the odds of curative treatment. (Source: Daily Express - Health)
Source: Daily Express - Health - September 22, 2022 Category: Consumer Health News Source Type: news
Common vitamin deficiency linked to a ‘fivefold’ increase in ‘stomach cancer’ risk
Protein and vitamin deficiencies are common side effects of cancer because inflammation often interferes with the body's mechanisms, but rarely are they identified as the cause of the disease. (Source: Daily Express - Health)
Source: Daily Express - Health - September 20, 2022 Category: Consumer Health News Source Type: news
Popular type of vegetable linked to a 50% higher risk of cancer - 'good idea' to swap out
THE ASSOCIATION with stomach cancer was based on a meta-analysis of 14 studies. In light of the link to, it's a "good idea" to swap out the vegetable for healthier equivalents, advises a leading health body, which was not involved in the study. (Source: Daily Express - Health)
Source: Daily Express - Health - September 15, 2022 Category: Consumer Health News Source Type: news
Fred Rogers had a 'good deal of indigestion' when a cancerous tumour grew in his stomach
FRED ROGERS is best known for Mister Rogers' Neighbourhood, which ran from 1968 to 2001, and two years later, cancer took his life. (Source: Daily Express - Health)
Source: Daily Express - Health - September 13, 2022 Category: Consumer Health News Source Type: news
Student, 21, mistook cancer symptoms for university workload stress and hangovers
Molly Hunt, of Chesham, Buckinghamshire, began experiencing stomach pain after drinking in October last year, while in the second year of her Geography degree. (Source: the Mail online | Health)
Source: the Mail online | Health - August 31, 2022 Category: Consumer Health News Source Type: news
BMJ review finds 'evidence' that a type of vegetable increases risk of stomach cancer
CANCER remains a leading cause of death in the world, despite groundbreaking efforts to expunge it. Modifying your risk is one of the best weapons in your arsenal. A recent BMJ review shone a light on "evidence" indicating a type of vegetable might increase risk of stomach cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - August 30, 2022 Category: Consumer Health News Source Type: news
Cancer: 'Extremely worrying' people don't know the common symptoms of leukaemia - signs
CANCER is a condition that can affect any part of the body, from the brain to the stomach, and from the bowel to the skin. When cancer strikes, it is important to take action as soon as possible in order to save a life. However, the key to spotting cancer lies in knowing the symptoms, an area which charities are growing increasingly concerned about. (Source: Daily Express - Health)
Source: Daily Express - Health - August 25, 2022 Category: Consumer Health News Source Type: news
Intensive Endoscopy Might Not Be One-and-Done for Gastric Cancer Surveillance
(MedPage Today) -- The use of intensive index endoscopy was not associated with subsequently reduced detection of new gastric cancers after 1 year for high-risk patients, according to a case-control study from Japan.
Early gastric cancer detection... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - August 23, 2022 Category: Gastroenterology Source Type: news
Epstein-Barr Virus Linked With Gastric Cancer
(MedPage Today) -- A substantial proportion of gastric cancers worldwide was linked with the Epstein-Barr virus (EBV), according to a meta-analysis.
In a pooled analysis involving over 68,000 patients with conventional gastric adenocarcinoma in... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - August 12, 2022 Category: Gastroenterology Source Type: news
Study Suggests Relationship Between Stromal Tumors and Mesothelioma
Early identification of peritoneal mesothelioma cancer – when it is most effectively treated – may become more common after a recent study revealed a potential link to gastrointestinal stromal tumors.
A single-center retrospective review by the division of surgical oncology at University of California San Diego Moores Cancer Center identified a previously underrecognized, synchronous co-occurrence between the two rare diseases.
Annals of Surgical Oncology published the case series in July, which found that one in every 17 patients undergoing resection for gastrointestinal stromal tumors, known as GISTs, also had ...
Source: Asbestos and Mesothelioma News - August 2, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Peritoneal Source Type: news
